Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.50 Billion | USD 8.49 Billion | 21.28% | 2023 |
According to the report published by Zion Market Research, the global Roadside Drug Testing Devices Market size was valued at USD 1.50 Billion in 2023 and is predicted to reach USD 8.49 Billion by the end of 2032. The market is expected to grow with a CAGR of 21.28% during the forecast period.
The report analyzes the global Roadside Drug Testing Devices Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Roadside Drug Testing Devices industry.
Roadside drug testing is utilized to identify the presence of the drugs in humans by extracting biological samples like urine, blood, & hair and further analyzing them. The roadside drug testing devices also assist in examining the level of drugs in the blood. These devices are compact handheld testing equipment that also utilizes the breath specimens of the driver.
The presence of stringent laws regarding the consumption of alcohol and drugs across all the regions is fuelling the growth of the global roadside drug testing devices market. Furthermore, the growing number of accidents due to driving after consuming alcohol or drugs will further escalate the need for roadside drug testing. Alcohol and drug abuse are growing at an alarming rate all across the globe, which in turn is resulting in an increasing focus of authorities on ramping up drug and alcohol testing.
However, such emerging scenarios are creating several lucrative growth opportunities in the global roadside drug testing devices market. In addition, the surging utilization of rapid oral fluid screening devices by independent laboratories to perform diagnostic procedures will also support the growth of the market. The companies involved in the roadside drug testing devices are boosting their production capabilities to manufacture innovative handheld devices.
Furthermore, the companies in the market are able to conduct improved analyses of psychomotor functioning and cognitive behavior of individuals via clinical trials due to the introduction of advanced driving simulators. The ongoing technological advancements and innovations in the field of testing devices are likely to improve accuracy by minimizing errors. Companies are building lightweight devices which are user-friendly and can collect a large number of samples. Also, they are making constant efforts to develop devices that can easily detect even the low quantity of THC analytes.
The global roadside drug testing devices market can be segmented into substance, sample type, modality, and region.
By substance, the market can be segmented into alcohol and drugs. The alcohol segment accounts for the largest share in the global roadside drug testing devices market. However, the drug segment is likely to be the fastest-growing segment during the forecast period. The drug segment can further be bifurcated into opioids, benzodiazepines, amphetamine, cocaine, tetrahydrocannabinol, and others.
By sample type, the market can be segmented into urine, sweat, saliva, and others. The others segment including the breath specimen holds the largest share in the global market.
By modality, the market can be segmented into standalone and handheld devices. The handheld devices segment holds hegemony over others due to its ease of use and portability feature.
Report Attributes | Report Details |
---|---|
Report Name | Roadside Drug Testing Devices Market |
Market Size in 2023 | USD 1.50 Billion |
Market Forecast in 2032 | USD 8.49 Billion |
Growth Rate | CAGR of 21.28% |
Number of Pages | 205 |
Key Companies Covered | MangalIndia.com, Inc., Lifeloc Technologies, Inc., Intoximeters, EnviteC, Drägerwerk AG & Co. KGaA, Cannabix Technologies Inc., BACtrack, Alcohol Countermeasure Systems Corp, Akers Biosciences, Inc., AK GlobalTech Corporation., Securetec, and UriTox, LLC, Pacific Data Systems Pty Ltd, MAVAND Solutions GmbH, CareHealth America, Oranoxis Inc., and Abbott Laboratories |
Segments Covered | By substance, By sample type, By modality and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America accounts for the largest share in the global roadside drug testing devices market due to the growing number of drug and alcohol consumers in the region. Also, the alarming cases of accidents owing to the drunk drivers will further promulgate the growth of the regional market. The ongoing technological advancements in the field of roadside drug testing devices in the region to launch compact and advanced testing kits are likely to further propel the growth in the forthcoming years.
Europe accounts for the second-largest share in the global roadside drug testing devices market due to the high consumption of drugs and alcohol among the population in the region.
However, Asia Pacific is expected to be the fastest-growing region in the forthcoming years due to the growing disposable income of the people in the region.
The global roadside drug testing devices market is led by players like:
By Substance
By Sample Type
By Modality
Global Roadside Drug Testing Devices Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
Roadside drug testing is employed to detect the presence of drugs in humans by extracting biological samples such as urine, blood, and hair and subsequently analyzing them. In addition, the roadside drug testing instruments aid in the assessment of the blood drug level. The breath specimens of the motorist are also utilized by these compact handheld testing devices.
The global roadside drug testing devices market is experiencing growth due to the existence of stringent laws regarding the consumption of alcohol and narcotics in all regions. Additionally, the necessity for roadside drug testing will be further exacerbated by the increasing number of accidents that occur as a result of driving after consuming alcohol or drugs. Authorities are increasingly emphasizing the need to increase drug and alcohol testing due to the alarming increase in alcohol and drug abuse worldwide.
According to the report published by Zion Market Research, the global Roadside Drug Testing Devices Market size was valued at USD 1.50 Billion in 2023 and is predicted to reach USD 8.49 Billion by the end of 2032.
The market is expected to grow with a CAGR of 21.28% during the forecast period.
North America accounts for the largest share in the global roadside drug testing devices market due to the growing number of drug and alcohol consumers in the region. Also, the alarming cases of accidents owing to the drunk drivers will further promulgate the growth of the regional market. The ongoing technological advancements in the field of roadside drug testing devices in the region to launch compact and advanced testing kits are likely to further propel the growth in the forthcoming years.
Some of the significant players in the global roadside drug testing devices market are MangalIndia.com, Inc., Lifeloc Technologies, Inc., Intoximeters, EnviteC, Drägerwerk AG & Co. KGaA, Cannabix Technologies Inc., BACtrack, Alcohol Countermeasure Systems Corp, Akers Biosciences, Inc., AK GlobalTech Corporation., Securetec, and UriTox, LLC, Pacific Data Systems Pty Ltd, MAVAND Solutions GmbH, CareHealth America, Oranoxis Inc., and Abbott Laboratories.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed